B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cellsin vitro

This publication has 18 references indexed in Scilit:

• Early signaling defects in human T cells anergized by T cell presentation of autoantigen.
  The Journal of Experimental Medicine, 1992
• Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.
  The Journal of Experimental Medicine, 1992
• CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
  The Journal of Experimental Medicine, 1992
• Stimulation of Peripheral Blood T Cells by an Activated T‐Cell Line: a Novel Human Autologous T‐T Lymphocyte Reaction
  Scandinavian Journal of Immunology, 1991
• Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway
  Cellular Immunology, 1991
• A Cell Culture Model for T Lymphocyte Clonal Anergy
  Science, 1990
• Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction.
  The Journal of Experimental Medicine, 1990
• Role of the CD28 receptor in T-cell activation
  Immunology Today, 1990
• Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation Pathway
  Science, 1989
• Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor Occupancy
  Annual Review of Immunology, 1989